Gustavsson, A <br/><br/>
G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease.  [electronic resource] 

 -  Acta oncologica (Stockholm, Sweden)  1997 
 - 483-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0284-186X 
<br/><br/><label>Standard No.: </label>10.3109/02841869709001303  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bleomycin--administration & dosage<br/>Case-Control Studies<br/>Dacarbazine--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Female<br/>Filgrastim<br/>Follow-Up Studies<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Hematinics--administration & dosage<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Male<br/>Mechlorethamine--administration & dosage<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Neoplasm Staging<br/>Nervous System--drug effects<br/>Neutropenia--chemically induced<br/>Prednisone--administration & dosage<br/>Procarbazine--administration & dosage<br/>Recombinant Proteins<br/>Remission Induction<br/>Retrospective Studies<br/>Survival Rate<br/>Thrombocytopenia--chemically induced<br/>Treatment Outcome<br/>Vinblastine--administration & dosage<br/>Vincristine--administration & dosage